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Abstract
Background
To ensure the successful treatment of infectious disease using antimicrobial therapy, a sufficient concentration 
of the stable, active drug is required at the site of infection. For the achievement of this with respect to the 
ß-lactam group of antibiotics, of which amoxicillin is a member, the presence of an intact ß-lactam ring is 
essential. Destruction of this sensitive ring can lead to the ingestion of an inactive drug. This can contribute 
to treatment failure and antibiotic resistance. Thus, the aims of this study were to determine whether the types 
of packaging in which amoxicillin preparations are dispensed and the temperature and humidity conditions 
under which they are stored by patients are adequate and appropriate to ensure drug stability.
Methods 
A mini-survey of pharmacies and patients was conducted in order to determine the types of packaging in 
which amoxicillin preparations are dispensed and the temperature and humidity conditions under which they 
are stored by patients. The amoxicillin preparations in the identified types of packaging were subjected to 
simulated conditions that represented the identified temperature and humidity stresses that occurred under 
patient storage conditions for a duration of 14 days. The extent of breakage of the ß-lactam ring was then 
chemically determined on day 1, day 7 and day 14, using an iodometric titration method. 
Results
The mini-survey identified four types of packaging in which amoxicillin capsules are dispensed – plastic 
packets, flip-top amber bottles, flip-top amber bottles with cotton wool and flip-top transparent bottles with 
cotton wool. The laboratory analyses showed that only those amoxicillin capsules stored between 20 and 
25 0C and protected from moisture were stable in all four identified types of packaging for 14 days. The 
mini-survey also indicated that 47% of the patient sample did not store their antibiotic suspensions in the 
refrigerator. The laboratory analyses showed that only amoxicillin suspensions stored between 2 and 8 0C for 
seven days showed the lowest level of degradation. 
Conclusion
The results of this study indicate that reconstituted amoxicillin suspensions should be stored in the temperature 
range 2 to 8 0C, and that the reconstitution and dispensing of a 14-day supply of amoxicillin suspensions 
should be discouraged, even if the drug is stored in this temperature range. For amoxicillin capsules, the 
results obtained in this study indicate that significant breakage of the ß-lactam ring of amoxicillin capsules 
can occur in hot and humid climatic conditions if inadequate types of packaging are used and storage occurs 
under inappropriate conditions. The results of the study point to the importance of drug stability knowledge 
as a prerequisite for the dispensing of medicines, the importance of the provision of patient counselling with 
regard to drug storage requirements, as well as a requirement for amoxicillin capsules to be dispensed in the 
original manufacturers’ containers in geographical areas that are hot and humid.
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Introduction
Some of the major concerns 
expressed by healthcare practi-
tioners with regard to drug stability 
are the effects of the environmental 
stresses to which drug products are 
exposed throughout a product’s 
lifetime and the effects of such 
exposure on a product’s integrity.1 
The packaging of a dispensed 
medicine is an integral part of the 
product.2 It thus is important to 
ensure that containers are not only 
convenient for use by the patient, 
but also that they are sufficiently 
robust to protect the contents from 
the mechanical hazards of handling, 
transport and environmental stress.2
Stability assessment starts with 
stress testing – the application of a 
suitable stressor or challenge to the 
medicine – and the measurement 
of the effects of such a stressor 
on the physical and chemical 
properties of the medicine in the 
dispensed packages at appropriate 
time intervals.2 The principal tests 
used as part of stability studies 
are storage tests on the product, 
which are carried out under 
controlled stresses that represent 
the conditions expected during 
storage.3 The purpose of stability 
testing is thus to provide evidence of 
how the quality of the drug product 
varies with time under the influence 
of a variety of environmental factors, 
such as temperature, humidity and 
light, enabling the recommendation 
of storage conditions, re-test 
periods, beyond use dates and 
shelf life.2 
The chemical degradation 
of drugs can lead to the loss of 
potency of the product, therefore the 
person preparing and dispensing 
medicines must have full knowledge 
of the chemical nature of the 
substance being handled so that 
all the possible types and causes of 
degradation can be determined and 
suitable measures can be taken to 
retard these reactions. Drugs can 
degrade by various chemical 
reactions; the most common of 
which are oxidation, hydrolysis 
and racemisation. The rate of these 
reactions is affected by a variety of 
factors, such as pH, temperature, 
carbon dioxide, oxygen, light and 
humidity. Thus the stability of a 
medicine relates to the various 
changes that can occur in the 
medicine during preparation and 
storage, and to the effects of these 
changes on its fitness for use. Since 
drugs degrade by various chemical 
reactions, their degradation can 
often be retarded by the judicious 
selection of containers and 
closures and by controlling storage 
conditions.2
It is of particular importance 
that, during patient counselling, the 
patient is given advice with respect 
to the storage of medication, for 
example: store away from heat and 
direct light; do not store the capsules 
or tablet forms of amoxicillin in 
the bathroom, near the kitchen 
sink, or in other damp places; and 
store liquid forms of amoxicillin in 
the refrigerator because heat will 
cause the medicine to break down.4 
However, while proper storage 
conditions should be reinforced 
with the patient during patient 
counselling, it is also recognised 
that proper control beyond the 
dispenser can be difficult.5
Amoxicillin is a ß-lactam antibiotic. 
It contains a ß-lactam ring and has 
the following structure: 
Figure 1: Structure of amoxicillin
The dashed arrow,    , 
indicates the bond in the ß-lactam 
ring that is susceptible to breakage
The common name of amoxicillin 
is p-hydroxyampicillin and its 
chemical name is 6-< [amino- (4-
hydroxyphenyl) acetyl] amino>-3, 
3-dimethyl-7-oxo-4thia-1-azabicyclo 
[3.2.0] heptane-2-carboxylic acid.6 
Amoxicillin is a semi-synthetic 
penicillin antibiotic. Semi-synthetic 
refers to the chemical modification 
of a naturally occurring substance.7
A notable property of the ß-lactam 
ring is its ease of hydrolysis by 
aqueous acid, aqueous base and 
enzymatic conditions.8 The greatest 
single cause of antibiotic resistance 
to ß-lactam antibiotics arises from 
the irreversible hydrolysis of the 
amide bond in the ß-lactam ring 
by ß-lactamase enzymes.9 The 
activity of the ß-lactam antibiotic is 
thus dependent on the integrity of 
the ring. Breakage of this essential 
ring, as a result of the enzyme 
ß-lactamase that catalyses the 
hydrolysis of the amide bond of the 
lactam ring or the breakage of this 
bond brought about by external 
influences, can result in antibiotic 
resistance. 
Amoxicillin is used to treat an 
array of infections from the Gram 
negative to the Gram positive,7 and 
it is used widely in both the public 
and private sectors.10 The aim of 
antibiotic treatment is to maximise 
antibacterial activity to prevent a 
recurrence of infection and the 
creation of resistance pathogens. 
For ß-lactam antibiotics, the most 
important determinant of the 
antimicrobial efficacy, and hence 
predictor of therapeutic efficacy, is 
the length of time in which serum 
concentrations exceed the minimum 
inhibitory concentration (MIC). 
Dosing schedules for ß-lactam 
antibiotics should maintain serum 
concentrations above the MIC for 
the bacterial pathogen for at least 
50% of the dosing interval to achieve 
therapeutic efficacy and prevent the 
development of resistance. This 
is a basic criterion for the clinical 
efficacy of the ß-lactams.11 For this 
to occur, a certain defined quantity 
of a chosen antibiotic is given 
over a period of time to enable the 
attainment of levels higher than the 
MIC.
Therefore, the use of ß-lactam 
antibiotics that have experienced 
ring breakage due to fluctuations in 
the external environment can result 
in reduced antibacterial activity 
and the same drug given over a 
standard period may thus only 
attain levels lower than the MIC. This 
may not be in a concentration high 
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organism of infection, leading to an 
increase in the number of recurrent 
infections and the development of 
antibiotic resistance.
The aims of this study were to 
determine whether the types of 
packaging in which amoxicillin 
preparations are dispensed and 
the temperature and humidity 
conditions under which they are 
stored by patients are adequate and 
appropriate to ensure drug stability.
2  Method
Prior to the commencement of 
the study, ethical approval was 
granted by the Ethics Committee 
of the Faculty of Health Sciences, 
University of KwaZulu-Natal. The 
research method incorporated two 
stages, the mini-survey (Part A) and 
the laboratory analyses (Part B).
2.1 Part A: the mini-survey
A mini-survey of pharmacies 
and patients was conducted in 
order to determine the types of 
packaging in which amoxicillin 
preparations are dispensed and 
the temperature and humidity 
conditions under which they are 
stored by patients. Questionnaires 
were distributed to pharmacists 
and patients. The choice of the five 
community pharmacies used in the 
study was based on the inclusion 
in the sample of at least two urban 
and two suburban pharmacies. 
The patient sample consisted of 
100 pharmacy patients who had 
antibiotics dispensed to them. 
The data obtained was analysed 
using Microsoft ExcelR. The results 
obtained formed the basis for Part 
B,  the laboratory analyses.
2.2 Part B: the laboratory analyses
All chemicals used were of analytical 
grade and distilled water was 
used throughout. Pharmaceutical 
preparations of amoxicillin capsules 
and suspensions were obtained 
commercially. These preparations 
contained only one drug and did 
not exist in combination with other 
drugs.
The amoxicillin preparations in 
the identified types of packaging 
were subjected for 14 days to 
simulated conditions in the laboratory 
that represented the identified 
temperature and humidity stresses 
that occurred under patient storage 
conditions . The extent of breakage 
of the lactam ring was determined 
on day 1, day 7 and day 14 using 
an iodometric titration method. 
The percentage of degradation 
of each sample was calculated 
and compared to a 5% limit of 
degradation.10 Any value above 5% 
was considered to be significant 
degradation and the sample was 
thus considered unstable. 
Iodometric titrations are 
particularly suitable for the assay 
of penicillin antibiotics and their 
dosage forms. Penicillins with an 
open lactam ring are inactive as 
antibiotics, since it is the reactive 
lactam ring that kills the bacteria. 
When the lactam ring is opened 
it will react with iodine. One mole 
of the ring-open form of penicillin 
will react with eight equivalents of 
iodine; the intact lactam ring will 
not react. In this type of titration, 
excess iodine solution is added to 
a sample of the penicillin and the 
iodine that is not consumed in the 
reaction is calculated by a titration 
with sodium thiosulphate. The 
value obtained for the amount of 
hydrolysed penicillin in the sample 
should be no more than 5% of that 
obtained when all the penicillin 
in the same amount of sample is 
completely hydrolysed to the ring-
opened form and then reacted with 
iodine. Most of the pharmacopoeial 
monographs for penicillins indi-
cate that this test should be 
carried out.12 A pharmacopoeial 
monograph is a description of a 
drug in an authoritative publication, 
for example The United States 
Pharmacopoeia (USP).13
3  Results 
3.1 Part A: the mini-survey
The results of the mini-survey 
indicate that:
1.  Of the patient sample, 89% 
received their antibiotic 
capsules in flip-top plastic (FTP) 
containers, while the remaining 
11% received their antibiotic 
capsules in plastic packets. 
The types of containers in which 
the antibiotic capsules were 
dispensed are shown in Figure 
1.
2.  Of the patient sample, 49% 
stored their capsules in the 
bedroom, 44% stored their 
medication in common areas of 
the house and 7% stored them 
in the car. The distribution of 
storage areas is shown in Figure 
2.
Figure 1: Types of containers in which 
antibiotic capsules are dispensed









FTP AB WITH COTTON
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Figure 2: Patient storage areas (capsules)
3.  Of the patient sample, 
53% stored their antibiotic 
suspensions in the fridge, while 
the remaining 47% stored their 
suspensions in other common 
areas of the house. The storage 
areas of antibiotic suspensions 








Figure 3: Patient storage areas 
(Suspensions).
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3.2 Part B: The laboratory analyses
The extent of ß-lactam ring breakage 
was used as an indicator of drug 
stability. The iodometric titration 
results were used to calculate the 
percentage of ring breakage at the 
Table I:  A comparative analysis of the percentage of ring breakage of amoxicillin suspension using iodometric titrations at 
varying temperatures on day 1, day 7 and day 14 [limit < 5 %]





2-8 °C 2.10% 5.30% 6.80%
8-15 °C 2.30% 7% 8%
15-20 °C 2.40% 7.70% 10%
20-25 °C 2.50% 11.00% 14.00%
30-35 °C 11.30% 25% 31%





PLASTIC PACKET 2.60% 3.40% 4.90%
TB WITH WOOL 2.90% 3.50% 4.60%
AB WITHOUT WOOL 2.40% 3.0% 4.0%
AB WITH WOOL 2.30% 2.60% 3.50%
Table II: A comparative analysis of the percentage of ring breakage of amoxicillin capsules using iodometric titrations at 
temperatures of 20-25 0 C [moisture protected] on day 1, day 7 and day 14 [limit < 5 %]
Table III: A comparative analysis of the percentage of ring breakage of amoxicillin capsules using iodometric titrations at 
temperatures of 30-35 0C [moisture protected] on day 1, day 7 and day 14 [limit < 5 %]





PLASTIC PACKET 5.70% 13.80% 25.0%
TB WITH WOOL 4.40% 11.50% 20.0%
AB WITHOUT WOOL 4.9% 12.70% 21.0%
AB WITH WOOL 2% 6.30% 15.0%
varying temperatures and humidity 
levels on day 1, day 7 and day 14. 
The samples being analysed were 
considered unstable where values 
above the 5% limit of degradation 
were calculated. The results are 
reported in Table I below.
A comparative analysis of the 
percentage of ring breakage at 
different temperatures and relative 
humidity is provided in Tables II, III, 
IV and V.    
Table IV: A comparative analysis of the percentage of ring breakage of amoxicillin capsules using iodometric titrations at 
temperatures of 20-25 0C with ± 65% relative humidity on day 1, day 7 and day 14 [limit < 5 %]





PLASTIC PACKET 2.90% 4.20% 5.40%
TB WITH WOOL 3.00% 4.00% 4.70%
AB WITHOUT WOOL 2.70% 3.40% 4.30%
AB WITH WOOL 2.40% 3.30% 4.0%
Table V: A comparative analysis of the percentage of ring breakage of amoxicillin capsules using iodometric titrations at 
temperatures of 30-35 0C with ± 75% relative humidity on day 1, day 7 and day 14 [Limit < 5 %]





PLASTIC PACKET 15.70% 25.00% 41.00%
TB WITH WOOL 13.00% 19.40% 29.00%
AB WITHOUT WOOL 16.20% 23.30% 38.00%
AB WITH WOOL 11.00% 14.60% 25.00%
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4  Discussion
For the amoxicillin suspensions, 
the lowest level of degradation 
was seen at storage in the 
temperature range 2 to 8 0C for 
seven days. At 14 days in the 
same temperature range, 6.8% 
degradation was observed. Thus, 
amoxicillin suspensions that have 
been reconstituted and dispensed 
in appropriate volumes for 14 days’ 
treatment can have a reduced 
therapeutic effect by day 14, even 
if they are stored in the temperature 
range of 2 to 8 0C. At higher 
temperatures, significant breakage 
occurred from day 7 and, in the 
30 to 35 0C temperature range, 
significant breakage occurred as 
early as day 1. The mini-survey 
revealed that a large percentage of 
patients do not store their antibiotic 
suspensions in the refrigerator. 
With the temperature range in 
Durban (KwaZulu-Natal, South 
Africa) being between 31 and 42 
0C,14 the results of this study point 
to a decrease in the therapeutic 
efficacy and an increase in anti-
biotic resistance of these drugs if 
they are inadequately packaged 
and inappropriately stored. 
Furthermore, the reconstitution and 
dispensing of a 14-day supply of 
amoxicillin suspension should be 
discouraged due to the instability 
of the drug at day 14, even when 
stored between 2 and 8 0C.
With respect to the amoxicillin 
capsules, only those capsules that 
were stored in the temperature 
range 20 to 25 0C and that were 
protected from moisture were stable 
in all four of the identified types of 
packaging for 14 days. However, 
with an increase in the temperature 
range to 30 to 35 0C, only the 
capsules that were packaged in 
flip-top bottles were stable on day 
1, although the capsules in all four 
types of packaging were protected 
from moisture. With the introduction 
of the humidity variable, the 
capsules contained in all four 
identified types of packaging were 
stable in the temperature range 
of 20 to 25 0C and at a relative 
humidity of +-65%, except for the 
capsules that were contained in 
the plastic packets, which showed 
signs of significant degradation 
on day 14. With a further increase 
in the temperature range to 30 to 
35 0C and an increase in relative 
humidity to +-75%, the capsules 
that were contained in all four types 
of packaging showed significant 
degradation, even as early as day 
1. 
With a temperature range of 31 
to 42 0C and an average relative 
humidity range of 61 to 80% in 
Durban,14 the results of this study 
point to a decrease in therapeutic 
efficacy and an increase in 
antibiotic resistance of these drugs 
if they are inadequately packaged 
and inappropriately stored. Whilst 
the amoxicillin capsules packaged 
in amber flip-top containers with 
cotton wool displayed the most 
stable drug profile and those 
packaged in plastic packets 
displayed the least stable drug 
profile, the results obtained in 
the temperature range 30 to 35 
0C with +-75% relative humidity 
point towards a requirement for 
amoxicillin to be dispensed in the 
original manufacturers’ containers 
in geographical areas that are hot 
and humid.
5 Conclusion
The results of this study indicate 
that reconstituted amoxicillin 
suspensions should be stored in 
the temperature range 2 to 8 0C, 
and that the reconstitution and 
dispensing of a 14-day supply of 
amoxicillin suspension should be 
discouraged, even if the drug is 
stored in this temperature range.
Regarding amoxicillin capsules, 
the results obtained from this 
study indicate that significant 
breakage of the ß-lactam ring 
of amoxicillin capsules can 
occur in hot and humid climatic 
conditions if inadequate types of 
packaging are used and storage 
takes place under inappropriate 
conditions. These results point to 
the importance of drug stability 
knowledge as a prerequisite for 
the dispensing of medicines, the 
importance of the provision of 
patient counselling with regard 
to drug storage requirements, as 
well as the necessity for amoxicillin 
capsules to be dispensed in the 
original manufacturers’ containers 
in geographical areas that are hot 
and humid.
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